1st Counsel – Lifestyle
Author:
Erasca, Inc.
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
March 12, 2026
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
March 10, 2026
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
March 5, 2026